StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc.

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3025% above fair value
$682.65−14.35 (-2.06%)

Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%

Thermo Fisher Scientific R&D as % of Manufacturing Revenue by Year

R&D as % of Manufacturing Revenue (%)

Thermo Fisher Scientific R&D as % of Manufacturing Revenue: 7.0% in FY2025, down 0.2 pts from a year earlier.

Latest, FY2025
7.0%
Period ended Dec 31, 2025
Change on a year earlier
-0.2 pts
7.2% in FY2024
History
4 years
Since FY2022
Sources
4
Documents cited below

Where the FY2025 figure comes from

“R and D as a percent of our manufacturing revenue for the year was 7%.”

Source: Q4 2025 Earnings Call Transcript (2026-01-29) ↗

Core R&D intensity metric disclosed by the CFO on earnings calls (excluding distribution services and CRO revenue from the denominator). On the Q4 call, the CFO discloses the full-year figure.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedR&D as % of Manufacturing Revenue (%)Year on yearSource
FY2025Dec 31, 20257.0%-0.2 ptsQ4 2025 Earnings Call Transcript (2026-01-29) ↗
FY2024Dec 31, 20247.2%+0.4 ptsQ4 2024 Earnings Call Transcript (2025-01-30) ↗
FY2023Dec 31, 20236.8%+0.4 ptsQ4 2023 Earnings Call Transcript (2024-01-31) ↗
FY2022Dec 31, 20226.4%–Q4 2022 Earnings Call Transcript (2023-02-01) ↗

Breakdown

What makes up R&D as % of Manufacturing Revenue

Cite this data

StockData. (2026). Thermo Fisher Scientific R&D as % of Manufacturing Revenue (%), annual FY2022–FY2025 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/rd-pct-mfg-rev

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.